4 days ago
HomeMarket NewsAstraZeneca Pharma India shares rise 8% after revenue, margin jump in Q4
Revenue for the quarter rose to ₹480 crore, while EBITDA nearly doubled from last year to ₹86 crore.
By Meghna Sen June 2, 2025, 9:36:50 AM IST (Published)
Shares of AstraZeneca Pharma India Ltd. are trading over 8% higher on Monday, June 2, after the company reported its January-March quarter results post market hours on Friday. With today's surge, the stock is extending its gains for the third consecutive session.
AstraZeneca's net profit for the company increased 47.7% year-on-year to ₹58.2 crore from ₹39.4 crore last year.
Revenue for the quarter rose by 25.4% from the same quarter last year to ₹480.4 crore. The company reported revenue of ₹383 crore in the same quarter last year.
The company's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) nearly doubled from last year, rising 75% to ₹86 crore from ₹49 crore last year.
EBITDA margin for the company increased by over 500 basis points to 17.96% from 12.89% in the year-ago quarter.
The AstraZeneca Pharma stock does not have any analyst coverage.
Shares of Astrazeneca Pharma India Ltd. are currently trading 8.13% higher at ₹8,620. The stock has risen nearly 30% in the last six months.
